Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markos Kalligeros

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Annals of Internal Medicine|January 15, 2019
In uncomplicated acute appendicitis, 61% of patients initially treated with antibiotics had not had appendectomy at 5 yearsMarkos Kalligeros, Eleftherios Mylonakis
Hepatobiliary Surgery and Nutrition|April 15, 2024
Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver diseaseMarkos Kalligeros, Emmanuel A Tsochatzis
Biology|October 23, 2021
Biomarkers in Small Intestine NETs and Carcinoid Heart Disease: A Comprehensive ReviewMarkos Kalligeros, Leonidas Diamantopoulos, Christos Toumpanakis
Gastroenterology & Hepatology|January 31, 2025
Noninvasive Assessment to Identify Patients With At-Risk Metabolic Dysfunction-Associated SteatohepatitisMarkos Kalligeros, Pojsakorn Danpanichkul, Mazen Noureddin
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 12, 2024
ReplyMarkos Kalligeros, Eleftherios Mylonakis, Mazen Noureddin
Journal of Brown Hospital Medicine|April 6, 2026
Signet-Ring Cell Carcinoma Masquerading as Crohn's Disease: A Diagnostic Challenge in Multifocal Colonic Strictures with AscitesIshan Antony, Markos Kalligeros, Samantha Zullow
Clinical and Molecular Hepatology|August 19, 2024
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseZobair M Younossi, Markos Kalligeros, Linda Henry
Metabolism: Clinical and Experimental|August 25, 2024
Metabolic dysfunction-associated steatotic liver disease and its link to cancerMarkos Kalligeros, Linda Henry, Zobair M Younossi
Clinics in Liver Disease|May 16, 2026
Noninvasive Testing for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisMarkos Kalligeros, Laurent Castera, Emmanuel A Tsochatzis, et al.
Frontiers in Pharmacology|February 23, 2023
Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort studyYazed Saleh Alsowaida, Fadi Shehadeh, Markos Kalligeros, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Annals of Internal Medicine|January 15, 2019
In uncomplicated acute appendicitis, 61% of patients initially treated with antibiotics had not had appendectomy at 5 yearsMarkos Kalligeros, Eleftherios Mylonakis
Hepatobiliary Surgery and Nutrition|April 15, 2024
Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver diseaseMarkos Kalligeros, Emmanuel A Tsochatzis
Biology|October 23, 2021
Biomarkers in Small Intestine NETs and Carcinoid Heart Disease: A Comprehensive ReviewMarkos Kalligeros, Leonidas Diamantopoulos, Christos Toumpanakis
Gastroenterology & Hepatology|January 31, 2025
Noninvasive Assessment to Identify Patients With At-Risk Metabolic Dysfunction-Associated SteatohepatitisMarkos Kalligeros, Pojsakorn Danpanichkul, Mazen Noureddin
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 12, 2024
ReplyMarkos Kalligeros, Eleftherios Mylonakis, Mazen Noureddin
Journal of Brown Hospital Medicine|April 6, 2026
Signet-Ring Cell Carcinoma Masquerading as Crohn's Disease: A Diagnostic Challenge in Multifocal Colonic Strictures with AscitesIshan Antony, Markos Kalligeros, Samantha Zullow
Clinical and Molecular Hepatology|August 19, 2024
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseZobair M Younossi, Markos Kalligeros, Linda Henry
Metabolism: Clinical and Experimental|August 25, 2024
Metabolic dysfunction-associated steatotic liver disease and its link to cancerMarkos Kalligeros, Linda Henry, Zobair M Younossi
Clinics in Liver Disease|May 16, 2026
Noninvasive Testing for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisMarkos Kalligeros, Laurent Castera, Emmanuel A Tsochatzis, et al.
Frontiers in Pharmacology|February 23, 2023
Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort studyYazed Saleh Alsowaida, Fadi Shehadeh, Markos Kalligeros, et al.
Pageof 7